These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
640 related items for PubMed ID: 32990543
1. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents. Awolade P, Cele N, Ebenezer O, Kerru N, Gummidi L, Gu L, Palma G, Kaur M, Singh P. Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543 [Abstract] [Full Text] [Related]
2. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities. Yang M, Liu H, Zhang Y, Wang X, Xu Z. Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464 [Abstract] [Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents. Singh A, Kaur H, Arora S, Bedi PMS. Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100368. PubMed ID: 34783073 [Abstract] [Full Text] [Related]
5. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation. Kumar K, Sagar S, Esau L, Kaur M, Kumar V. Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212 [Abstract] [Full Text] [Related]
6. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Singh H, Singh JV, Gupta MK, Saxena AK, Sharma S, Nepali K, Bedi PMS. Bioorg Med Chem Lett; 2017 Sep 01; 27(17):3974-3979. PubMed ID: 28797799 [Abstract] [Full Text] [Related]
7. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Yan X, Lv Z, Wen J, Zhao S, Xu Z. Eur J Med Chem; 2018 Jan 01; 143():899-904. PubMed ID: 29227930 [Abstract] [Full Text] [Related]
8. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds. Guo H, Diao QP. Curr Top Med Chem; 2020 Jan 01; 20(16):1499-1503. PubMed ID: 32156238 [Abstract] [Full Text] [Related]
12. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid. Dhawan S, Awolade P, Kisten P, Cele N, Pillay AS, Saha S, Kaur M, Jonnalagadda SB, Singh P. Chem Biodivers; 2020 Jan 01; 17(1):e1900462. PubMed ID: 31788939 [Abstract] [Full Text] [Related]
14. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents. Kadhim ZY, Alqaraghuli HGJ, Abd MT. Anticancer Agents Med Chem; 2021 Jan 01; 21(17):2397-2406. PubMed ID: 33797379 [Abstract] [Full Text] [Related]
15. Synthesis, antimicrobial activity and cytotoxicity of triphenylphosphonium (TPP) conjugates of 1,2,3-triazolyl nucleoside analogues. Yu Strobykina I, Voloshina AD, Andreeva OV, Sapunova AS, Lyubina AP, Amerhanova SK, Belenok MG, Saifina LF, Semenov VE, Kataev VE. Bioorg Chem; 2021 Nov 01; 116():105328. PubMed ID: 34500307 [Abstract] [Full Text] [Related]
16. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells. Martínez-Muñoz A, Prestegui-Martel B, Méndez-Luna D, Fragoso-Vázquez MJ, García-Sánchez JR, Bello M, Martínez-Archundia M, Chávez-Blanco A, Dueñas-González A, Mendoza-Lujambio I, Trujillo-Ferrara J, Correa-Basurto J. Anticancer Agents Med Chem; 2018 Nov 01; 18(11):1629-1638. PubMed ID: 29745344 [Abstract] [Full Text] [Related]
17. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Rezki N, Almehmadi MA, Ihmaid S, Shehata AM, Omar AM, Ahmed HEA, Aouad MR. Bioorg Chem; 2020 Oct 01; 103():104133. PubMed ID: 32745759 [Abstract] [Full Text] [Related]
19. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship. Liu S, Wang S, Xu D, Pan B, Chen L, Zhao S, Xu Z, Zhou W. Drug Dev Res; 2023 Sep 01; 84(6):1175-1182. PubMed ID: 37165798 [Abstract] [Full Text] [Related]
20. Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides. Zieba A, Pindjakova D, Latocha M, Plonka-Czerw J, Kusmierz D, Cizek A, Jampilek J. Molecules; 2024 Aug 26; 29(17):. PubMed ID: 39274892 [Abstract] [Full Text] [Related] Page: [Next] [New Search]